You searched for "vascular"
UK Eye Genetics Group Annual Conference
9 June 2023
by Chloe M. Stanton, UK-EGG Treasurer, MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh Delegates including ophthalmic clinicians, clinical geneticists, genetic counsellors and research scientists travelled to Edinburgh from across the UK and Europe to attend...
XXI SARCS (State of the Art Refractive Cataract Surgery) Symposium 2023
16 June 2023
You are invited to XXI State of the Art Refractive and Cataract Surgery Symposium on Friday 16 June 2023 at the University of Hull. This is the place where brilliant minds from around the world come together to share their...
Yorkshire Retina Society Winter Meeting 2024
3 December 2024
by Madiah Mahmood, Junior Medical Education Fellow, Bradford Teaching Hospitals and Foundation Trust, UK; Ewan McCallum, Consultant Ophthalmologist, Bradford Teaching Hospitals and Foundation Trust, UK. The Yorkshire Retina Society is one of the largest regional subspecialty societies in the UK,...
Handbook of Retinal OCT (Second Edition)
Duker et al. present the second edition of their Handbook of Retinal OCT. It’s an upgrade from their last edition in many respects – there’s an enhanced digital version, the pages have a nice glossy sheen which makes it feel...Clinical Applications of Optical Coherence Tomography Angiography
Clinical Applications of Optical Coherence Tomography Angiography provides an informative, up-to-date review of the numerous applications of OCTA in ophthalmology. This book highlights the ways in which this relatively recent non-invasive imaging technique has been an invaluable tool for our...The Eye: A Very Short Introduction
25 April 2025
| Michael Milad
|
EYE - General
I am a big fan of the ‘Very Short Introductions’ series and find them a great way to gain a basic understanding of several topics, ranging from science to philosophy. The Eye: A Very Short Introduction is no exception. It...
Eye research: where next?
1 December 2017
| Rod McNeil
|
EYE - General
Eye research in the UK is underfunded relative to other areas of medical research and general awareness of sight loss and its prevention remains poor, messages that were reinforced in presentations and discussions during a recent research summit meeting in...
A revolution in modern genetic testing for the clinical management of ocular disease
1 August 2016
| Jane Ashworth, Chris Lloyd (Prof), Graeme Black
|
EYE - Cataract, EYE - Pathology, EYE - Vitreo-Retinal
Recent years have seen a huge increase in our understanding of the genetic factors underlying a wide variety of eye diseases. This has included common conditions such as glaucoma and age-related macular degeneration, as well as those conditions which have...
Pathway innovations to address cataract services post-COVID-19
1 June 2022
| Sam Evans, Tine Jacobs, Hari Kaneshayogan, Leo Feinberg, Conor Ramsden
|
EYE - Cataract, EYE - Refractive
Background The demand for cataract services prior to the COVID-19 pandemic was already recognised to be high and growing - in the face of an ageing population and reduced surgical thresholds. When added to the growth in demand for ophthalmic...
Fingolimod: ocular adverse effects
1 October 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
Cataract surgery in small adult eyes
This is a retrospective audit of a five year study period, between the periods of January 2006 to December 2010, where a surgical log book search was performed. The inclusion criteria of this study were intraocular lenses (IOL) power greater...Results of fixed aflibercept treatment regime in type 3 neovascularisation
1 April 2020
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this prospective study the authors evaluate the effect of intravitreal aflibercept injections in the treatment of naive type 3 neovascularisation using a fixed treatment regime. Fourteen eyes of 14 patients were studied. All patients were treated with intravitreal 2.0...